Skip to content
Search

Latest Stories

UK’s death toll goes up by 24 per cent to over 2,900

THE UK’s coronoavirus death toll has gone up by 24 per cent to 2,921, with 33,718 confirmed Covid-19 cases, said a health ministry statement on Thursday (2).

This was the third day in a row that the country witnessed one-day high increases in the death toll.


NHS England said that of the 561 people who died in English hospitals in the previous 24-hour cycle, 44 had no underlying health conditions. The age range of those without underlying health conditions was 25 to 100 years old.

The UK has one of the worst official death tolls in the world, after Italy, Spain, the United States, France, China and Iran.

A further 4,244 people were diagnosed with the infection in the past 24 hours, pushing the total to 33,718.

This was slightly fewer than the 4,324 new diagnoses yesterday and today's death toll was just a small increase of six.

The Department of Health statistics mean the UK's coronavirus death toll has almost quadrupled in six days from just 759 last Friday, March 27.

Earlier in the day, Prime Minister Boris Johnson promised to ramp up coronavirus testing after his government faced criticism for being slower than some European peers to roll out mass checks for front-line health workers and the population.

Britain initially took a restrained approach to the outbreak but changed tack after modelling showed a quarter of a million people in the country could die.

Johnson imposed more stringent measures, effectively shuttering the world's fifth-largest economy, but many experts said the government's decision came late.

Incidentally, an Ipsos MORI poll showed more than half of Britons think the government was too slow to order a lockdown.

The government also faced widespread criticism for having too few ventilators and too little testing.

"We're also massively increasing testing," Johnson said in a video message from a flat in Downing Street where he is self-isolating after testing positive himself.

"As I have said for weeks and weeks, this is the way through: this is how we will unlock the coronavirus puzzle, this is how we will defeat it in the end."

Johnson's message, posted on Twitter on Wednesday evening, followed pledges from his ministers to accelerate both antibody and antigen testing in days ahead after a slew of sometimes contradictory statements on numbers already checked.

Health Secretary Matt Hancock, who has also been in isolation after testing positive, will announce additional testing measures on Thursday, Johnson's spokesman said.

While Germany has been testing about 500,000 people a week, Britain's current capacity is about 13,000 a day, a figure the government said it was aiming to double by mid-April.

"EVERYBODY FRUSTRATED"

Tests are essential for both fighting the virus and nursing the economy back to health after what is expected to be the worst quarter in around a century.

Testing frontline health staff allows those with immunity to return to work while broader testing of the population would allow tens of millions of idled workers back to work.

Showing just how bad coronavirus could be for the economy, British Airways said it was in talks about suspending 32,000 employees, while a survey showed that more than a quarter of British companies had reduced staff levels.

So far, tests have been focused on those suspected to have the virus and admitted to hospital, but the government plans to increase testing of frontline healthcare staff to hundreds of thousands in coming weeks.

"Everybody involved is frustrated that we haven't got to the position yet that we need to get to," Paul Cosford, emeritus medical director of Public Health England, said of current testing levels.

When asked about the possibility of immunity certificates, Johnson's spokesman said Britain was watching what other countries were doing.

Ministers have suggested shortages of necessary chemicals were a factor, though the industry has said the necessary reagents are being manufactured and delivered to the National Health Service (NHS).

While the government has been forced on the defensive over mass testing, some scientists have questioned if testing the entire 1.1 million full-time NHS staff is the best use of resources.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less